Success Metrics

Clinical Success Rate

100.0%

Based on 2 completed trials

Completion Rate

100%(2/2)

Active Trials

2(50%)

Results Posted

50%(1 trials)

Phase Distribution

Ph phase_1

25%

Ph phase_2

25%

Ph phase_4

25%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

1(33.3%)

Phase 2Efficacy & side effects

1(33.3%)

Phase 4Post-market surveillance

1(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(2)

Completed(2)

Detailed Status

Completed2

Recruiting1

Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

100.0%

Most Advanced

Phase 4

Trials by Phase

Phase 11 (33.3%)

Phase 21 (33.3%)

Phase 41 (33.3%)

Trials by Status

completed250%

recruiting125%

active_not_recruiting125%

Recent Activity

2 active trials

Showing 4 of 4

recruitingphase_4

Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia

NCT02706795

Clinical Trials (4)

Showing 4 of 4 trials

NCT06195241Phase 4

Effects of DaxibotulinumtoxinA for Blepharospasm and Hemifacial Spasm

Recruiting

NCT05158166Phase 1

DaxibotulinumtoxinA Injection for Treatment of Adductor Spasmodic Dysphonia

Completed

NCT06154070

An Open Label, Study of DaxibotulinumtoxinA for Migraine Prevention

Active Not Recruiting

NCT02706795Phase 2

Dose-escalating Safety and Preliminary Efficacy of DaxibotulinumtoxinA for Injection in Cervical Dystonia

Completed

All 4 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 4